Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Press Seminar
July 29, 2002
- Fukujin Agrees on Prices with Only 20% of Hospitals by End of June
July 29, 2002
- Takara Bio to Develop New Gene Detection System with Nanosphere
July 29, 2002
- Taiyo Pharm Beefs Up Contract Manufacturing Business
July 29, 2002
- Roche Diagnostics: Simple Blood Glucose Determination System, Accu-Chek Active
July 29, 2002
- BUSINESS NEWS IN BRIEF
July 29, 2002
- Eiken, Sysmex Tie Up to Market Urinarysis System in China
July 29, 2002
- Major Domestic Firms Feel Cool to Pfizer's Move
July 29, 2002
- InCROM Establishes EuCROM to Handle CRO Business in Europe
July 29, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
July 29, 2002
- MEDICAL DEVICE NEWS IN BRIEF
July 29, 2002
- 4.3% of ex-Koseisho Officials Were Aware of Risk of Hepatitis Due to Fibrinogen
July 29, 2002
- Korosho to Set Examples in Reform
July 22, 2002
- GL for Treatment of Esophageal Cancer Prepared
July 22, 2002
- REGULATORY NEWS IN BRIEF
July 22, 2002
- Shortage of Pharmacists Unlikely: Korosho Survey
July 22, 2002
- Aiming to Become Agile, Nimble Innovative Drug Firm: Mr Kannan of Allergan
July 22, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 22, 2002
- Kyowa Hakko Pharma Business to Focus on Cancer, Allergy
July 22, 2002
- 11 of 15 Major Firms Introduce Researchers Rewarding Programs: Survey
July 22, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…